|
MTRR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.51850000035859E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59809999999982E-06 |
| Normal-vs-Stage2 |
3.768600E-04 |
| Normal-vs-Stage3 |
2.4415999999583E-08 |
| Normal-vs-Stage4 |
5.446400E-04 |
| Stage1-vs-Stage2 |
6.075600E-01 |
| Stage1-vs-Stage3 |
3.900400E-02 |
| Stage1-vs-Stage4 |
6.064400E-01 |
| Stage2-vs-Stage3 |
3.638800E-01 |
| Stage2-vs-Stage4 |
9.982000E-01 |
| Stage3-vs-Stage4 |
3.685400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.68059999752879E-08 |
| Normal-vs-AfricanAmerican |
7.351400E-04 |
| Normal-vs-Asian |
6.256100E-03 |
| Caucasian-vs-AfricanAmerican |
9.915400E-01 |
| Caucasian-vs-Asian |
1.437000E-01 |
| AfricanAmerican-vs-Asian |
3.404400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.95279999737741E-08 |
| Normal-vs-Female |
4.79789999952018E-07 |
| Male-vs-Female |
1.665840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.8994399999972E-05 |
| Normal-vs-Age(41-60Yrs) |
4.33760000140282E-08 |
| Normal-vs-Age(61-80Yrs) |
3.55780000005357E-06 |
| Normal-vs-Age(81-100Yrs) |
1.151870E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.930960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.696800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.210400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.799600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.553000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.979000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.186000E-04 |
| Classical-VS-Follicular |
1.282440E-01 |
| Classical-VS-Other |
2.112800E-01 |
| Classical-VS-Normal |
2.161900E-04 |
| Tall-VS-Follicular |
5.097900E-02 |
| Tall-VS-Other |
8.053400E-01 |
| Tall-VS-Normal |
2.30329999517664E-08 |
| Follicular-VS-Other |
4.992600E-01 |
| Follicular-VS-Normal |
1.6149799999976E-05 |
| Other-VS-Normal |
2.801800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.37579999948123E-07 |
| Normal-vs-N1 |
1.46209999996039E-06 |
| N0-vs-N1 |
6.224400E-01 |
|
|
